SG, W., DM, Q., JS, F., & B, C. (2023). Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US. JAMA network open, 6(5), e2316089. https://doi.org/10.1001/jamanetworkopen.2023.16089
Chicago Style (17th ed.) CitationSG, Weiner, Qato DM, Faust JS, and Clear B. "Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US." JAMA Network Open 6, no. 5 (2023): e2316089. https://doi.org/10.1001/jamanetworkopen.2023.16089.
MLA (9th ed.) CitationSG, Weiner, et al. "Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US." JAMA Network Open, vol. 6, no. 5, 2023, p. e2316089, https://doi.org/10.1001/jamanetworkopen.2023.16089.
Warning: These citations may not always be 100% accurate.